Condition: Cancer (Solid Tumors) · Vomiting · Cisplatin · Sponsor: Mahidol University
A phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting
This description comes directly from the study's public registry record.
Suthinee Ithimakin · +66898127440 · aesi105@yahoo.co.th
Always discuss trial participation with your own doctor first.
| Faculty of Medicine Siriraj Hospital, Mahidol University | Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07699276